Background The incidence of skin cancer in organ transplant recipients (OTRs) is very high, due mainly to long-term immunosuppressive therapy. The problem is particularly severe for OTRs living in Queensland, Australia, and results in significant mortality. Objectives To describe the experience of the first dedicated outpatient highthroughput transplant skin clinic in Queensland. Methods This prospective evaluation study was conducted at a newly established, outpatient transplant skin cancer surgery and surveillance clinic. Participants (89 OTRs and 12 non-OTRs) were referred to the Princess Alexandra Hospital Transplant Skin Clinic during December 2016 to May 2017, and were each followed for 3 months. Self-completed questionnaires were administered at baseline and the end of follow-up (n = 94), and details of any skin cancers occurring in that period were extracted from hospital records. Results In the 3-month follow-up of 101 participants, a total of 615 skin lesions were detected in the 3-month follow-up of 101 participants, of which 478 (78%) were treated in the clinic and 55 (9%) were referred to another specialist. Of the 478 treated lesions, 268 were histopathologically confirmed skin cancers, equivalent to 2Á7 (95% confidence interval 2Á5-2Á8) skin cancers per participant per 3 months. The overall number needed to treat for any skin cancer was 1Á4 (95% confidence interval 1Á3-1Á5). Three-quarters (374) of in-clinic treatments were surgical, and most (90%) were complete excisions. The median time from detection of skin cancer to excision was 7 days. Conclusions This high-volume surgical outpatient transplant skin clinic enables efficient treatment of skin cancers in very-high-risk OTRs.
• The skin cancer burden in OTRs living in regions with high background incidence can be successfully managed by dedicated outpatient dermatological surgical clinics.
Organ transplant recipients (OTRs) have a greatly increased risk of skin cancer, 1 with the overall incidences of squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) in OTRs being some 30 times higher than in the general population. 2 The high risks of these keratinocyte cancers and of melanoma 3 in OTRs are caused by the combined effects of solar ultraviolet radiation and immunosuppressive treatment. 1, 4, 5 Skin cancer morbidity and mortality in OTRs rise steeply with age, age at transplantation and duration of immunosuppression. 6, 7 With greater potency of modern immunosuppressive drugs 8 and improvements in graft survival, 9 fair-skinned OTRs around the world are surviving longer and the incidence of skin malignancies will only continue to increase. Specialist clinics dedicated to regular skin surveillance of OTRs are vital for early treatment and control of skin cancers. 10, 11 Such a service is especially needed in Queensland, Australia, with its high background skin cancer rates in the general population reaching an annual incidence above 2000 per 100 000. 12 More specifically, we have previously reported that 11% of OTRs in Queensland are affected by SCC at any given point, clearly demonstrating the burden to be expected in such a target population. 13 Traditional pathways of clinical diagnosis, biopsy and referral for therapy are ineffective in managing such a high-risk population, and result in delays in treatment.
To better control the extreme skin cancer problem in local OTRs, a transplant skin clinic was thus established in Brisbane for dedicated outpatient management of skin cancer in veryhigh-risk OTRs. The specific aims of this study were to evaluate the workload of the clinic and patient outcomes by documenting the frequency and outcomes of skin examinations and skin cancer treatments among attendees. We also assessed attendee OTRs' satisfaction with treatment.
Patients and methods

Study population and setting
This study was conducted at the Princess Alexandra Hospital, in the newly established outpatient transplant skin clinic, which was implemented in March 2016 to expedite skin cancer treatment and provide health education to high-risk OTRs. The clinic staff comprises three teams: (i) a dermatology team of one consultant and multiple registrars; (ii) a surgical team, consisting of a senior surgeon (who determines the optimal excision modalities), a group of surgical registrars and residents participating in procedures; and (iii) a transplant team, many of whom crossparticipate in the surgical team. Plastic surgeons, radiation oncologists and kidney and liver physicians are on call. The clinic operates one afternoon each week, and additional complex surgeries may be booked on other days of the week. The staff sees an average of eight patients per clinic session (Fig. 1 were eligible to take part. Clinic attendees were those referred by nephrologists, transplant physicians or dermatologists from the Princess Alexandra Hospital, and/or through self-referral. Patient referral to the clinic was based on skin cancer risk assessed as very high, history of skin cancer and presence of severe photodamage. Patients were excluded if they were unable to give fully informed consent. The study procedures were approved by the QIMR Berghofer Human Research Ethics Committee (P2257) and the Metro South Human Research Ethics Committee (HREC/16/QPAH/703).
Clinical management
OTR patients were systematically reviewed in the clinic by dermatologists on a 3-monthly basis. Suspicious lesions were fully excised with appropriate margins based on the suspected diagnosis. This allowed a reduction in the common delay between clinical diagnosis to biopsy to excision that often results in the increased burden of the disease.
Excision surgery was performed by transplant or plastic surgeons immediately in the outpatient setting, or in the coming week in surgical theatre for more complex interventions. Patients were also offered preventive therapy and advice, and a review was organized in the next 3 months.
Data collection
At baseline, participants completed a self-administered questionnaire covering personal and sociodemographic characteristics (age, sex, employment status, education level, country of birth, ancestry), skin phototype and sun exposure habits, and medical histories. Each participant was followed up for 3 months, and during that period details of the frequency of clinic visits, skin examinations and treatments or referrals to other clinical specialties were recorded. After the 3 months we readministered the questionnaires to ascertain changes to transplant medications, subsequent visits to the transplant skin clinic, and satisfaction with the clinic. Participant satisfaction with the clinic was assessed by five questions. The first asked participants to rate the clinic for meeting patient needs, using a five-point Likert scale ranging from 'poor' to 'excellent'. The other four questions assessed the performance of the clinic and the aspects that participants liked or disliked, again using a five-point Likert scale ranging from 'not at all' to 'very much'.
Histopathology reports of all suspicious lesions clinically diagnosed and either treated or referred were collected for the 3 months of follow-up of each participant in the study, and biopsy methods and dates of diagnosis of single or multiple cancers were extracted to assess the surgical burden and skin cancer outcomes. Date(s) of transplantation(s) and immunosuppressive therapy regimens were obtained from medical records.
Data analysis
All data were cleaned and checked for errors against the original surveys and medical records. Baseline characteristics, clinic treatments and procedures, histopathological diagnoses and OTR referrals for management of skin lesions over the 3-month follow-up were summarized for all participants. We calculated the number of skin cancers per participant; the denominator included the total person-time contributed by each participant and the numerator included all histopathologically confirmed skin cancers during the 3-month follow-up. We also calculated the number needed to treat (NNT) by dividing the total number of biopsied or excised lesions by the total number of histopathologically confirmed skin cancers.
Results
Of 111 adults attending the transplant skin clinic and invited to participate, 101 (91%) agreed, and of these 94 (93%) completed the follow-up questionnaire. Those who declined to take part were predominantly men (91%), of average age 55 years.
Of the 101 participants at baseline (average age 63 years, 77% men, 78% of British or Irish descent), 89 were OTRs and 12 were awaiting transplantation and/or had a history of many skin cancers. Of the 89 OTRs, 79 had received a kidney and eight a liver (representing around 10% of kidney transplant and 1% of liver transplant recipients followed up at the Princess Alexandra Hospital), one had received a lung and one a heart. The transplantations had been performed on average 14 years previously. Those awaiting transplants represented around 5% of patients awaiting kidney transplantation annually, and although only two were using immunosuppressive medication, they were similar in sociodemographic characteristics to the 89 OTRs. Half (49%) were on triple immunosuppressive therapy. Over half (56%) of participants did not complete high school and 41% were considered to have low income (Table S1 ; see Supporting Information). Nearly half (49, 48%) reported a tendency to burn on acute sun exposure, about one-quarter (27, 27%) reported having mostly outdoor occupations in life, and 42 (42%) reported mainly outdoor recreational activities.
During their 3-month follow-up periods, the 101 study participants attended the clinic on a total of 224 occasions, with a median attendance of 2 [interquartile range (IQR) 1-3] per participant. During their cumulated follow-up, clinic staff performed 141 full-skin examinations and detected 615 suspicious skin lesions, of which 478 (78%) were managed by surgical and/or other modality by the team. The majority (374, 74%) of in-clinic procedures were surgical (337 complete excisions, 32 shave excisions, five punch biopsies; Table 1 ), performed either under local anaesthesia or in the operating room under general anaesthesia. The median time between lesion detection and definitive surgical treatment was 7 days (IQR 0-31), with over one-third (152) of lesions undergoing therapeutic excision on the day of detection. A median of 2 lesions (IQR 1-4) were excised per patient per visit, with the highest number being 24 excised in a single visit.
Fifty-five (9%) of the lesions detected in the clinic (from 17 participants) were referred to another specialist: plastic surgeon (24), surgeon (16), radiotherapy (seven) and dermatologist (three). They were detected mostly (34, 62%) within the hospital or by a general practitioner (five). Of the 55 lesions, 51 were referred without treatment and four lesions were referred after destructive treatment. The majority of referrals were for complex cases (i.e. plastic surgery) or for ongoing treatment. Over their 3-month follow-up, 12 participants (13%) reported that their transplant medication had been altered solely because of their skin cancers. This change was the result of direct communication that took place between clinic staff and transplant physicians.
In total, 101 participants had 268 histopathologically confirmed skin cancers (93 SCCs, 114 Bowen disease, 22 keratoacanthoma, 38 BCCs, one melanoma in situ) during their follow-up (Table 2) , equivalent to 2Á7 (95% confidence interval 2Á5-2Á8) skin cancers per participant per 3 months. These 268 cancers were diagnosed from a total of 374 suspicious skin lesions that were biopsied or excised, yielding an NNT of 1Á4 (95% confidence interval 1Á3-1Á5) for any skin cancer. Of the confirmed SCCs, 35 (42%) were well differentiated, 44 (52%) were moderately differentiated and five (6%) were poorly differentiated; four (4%) SCCs were > 2 cm in diameter and eight (10%) had invaded beyond the dermis. The majority of the excised BCCs were solid or nodular (24, 65%). The sites most affected were the upper limbs with 106 (40%) and the head and neck with 84 (31%). The remainder were on the lower limbs (57, 21%), the chest (12, 5%) and the back (nine, 3%).
The majority of the study participants (88%) rated the transplant skin clinic as 'very good' or 'excellent' for attending to their needs, and nearly all (95%) reported that they were very satisfied with the performance of the clinic. Most (79, 85%) agreed strongly that they liked attending because they received all of their skin cancer treatment in one clinic, 70 (76%) agreed strongly that it saved them worrying about their skin cancers while they waited for surgery, and 63 (77%) felt they received superior care for their skin cancers at the transplant skin clinic.
Discussion
This is the first report of the performance of a dedicated highthroughput transplant skin cancer clinic in Australia. Our results indicate that such a clinic meets a high demand by detecting and treating numerous skin cancers in high-risk OTRs, as well as managing the referral of many complex skin cancers. The clinic's achievement of such a high volume of surgical treatments can be attributed to its highly experienced and multidisciplinary specialist staff. 10, 11, 14, 15 Also as a result of the tertiary hospital setting, the clinic staff can communicate and consult regularly with other specialists across various hospital departments and with a large number of community healthcare practitioners, often at point of care (with patients generally seen within 2 weeks of referral). This coordination of care enables the clinic staff to triage OTRs presenting with skin cancers efficiently within a median of < 7 days and to provide full skin surveillance 3 monthly, fulfilling the aim of appropriate treatment in a time-effective manner.
Three-quarters of all in-clinic treatments provided were surgical, of which 90% were complete excisions. In keeping with previous studies, there were substantially more SCCs treated than BCCs. 14, 16, 17 As expected, the observed rate of skin cancer excisions performed in this clinic surpassed that of nonspecialized skin cancer surveillance clinics, [18] [19] [20] highlighting the fact that OTRs have an increasingly high risk of recurring and aggressive skin cancers compared with the general Values are n (%). population. This shows that complete and early excision of skin cancers in this vulnerable group is critical. 1 A noteworthy finding was that the number of lesions excised per patient visit was high, with numbers reaching up to 24 in one patient visit. This high-volume treatment will likely lead to far fewer outpatient visits by the OTRs, reduce their out-of-pocket costs, and bring cost savings for the Princess Alexandra Hospital. Further research is required to quantify these potential savings.
The NNT for any skin cancer was 1Á4 (i.e. 1Á4 skin lesions were excised or biopsied to identify one skin cancer). Although direct comparisons are difficult due to differences in case ascertainment, inclusion criteria and sampling, our estimate was lower than those reported by previous studies that included keratinocyte skin cancers in their estimates. 21, 22 We had expected that this clinic would perform well because it is specialist led and dedicated to surgery and surveillance in high-risk, highly selected OTRs. The main cause for misdiagnosis was solar keratoses, which can be hypertrophic and therefore mimic Bowen disease or SCC lesions. Our data demonstrate that skin cancers are effectively identified and efficiently managed by treating a high volume of skin cancers without the use of unnecessary biopsy. Attending OTRs reported being very satisfied with the clinic's performance. In particular, OTRs appreciated receiving all of their skin cancer treatment in the one clinic, and reported that it saved them from worrying about their skin cancers while awaiting definitive surgery. Prior to establishment of this clinic, OTRs typically attended multiple departments within the Princess Alexandra Hospital on multiple occasions to have their skin examined, suspicious lesions biopsied and suspected skin cancers excised. Previous clinical pathways also included multiple referrals -from transplantation physicians to dermatologists -where multiple visits were required for diagnosis, biopsy and finally definitive treatment or referral to surgeons. With the advent of the transplant skin clinic, OTRs could now have routine (approximately 3-monthly) skin examinations and receive all of their skin cancer treatment at once. In summary, this 'one-stop shop' reduced patient waiting times and facilitated early skin cancer treatment.
While the generalizability of our findings may be limited by our sample size and limited follow-up period, our participants were very similar to those from the much larger Skin Tumours in Allograft Recipients (STAR) study, who represented the majority of high-risk OTRs attending the Princess Alexandra Hospital. 13 Important strengths of this study included the use of medical charts to confirm personal and medical data, and the 9 months of cumulated data collection, which eliminated effects of seasonality.
In conclusion, with improvements in transplantation techniques, the burden of skin cancers in ageing OTRs will continue to grow unless effective surveillance and treatment measures are put in place. Our findings indicate that specialist outpatient skin cancer clinics for OTRs, such as the Princess Alexandra Hospital Transplant Skin Clinic described here, provide timely skin surveillance and prompt, highvolume treatment of skin cancers. They thereby make significant contributions to controlling the skin cancer burden in OTRs.
